Table. Accelerated immunisation schedule for infants, children and adults likely to require solid organ transplant
| Age | Vaccine | Comments |
|---|---|---|
| 6 weeks (do not start vaccination earlier than age 6 weeks) | Rotavirus | Do not give <4 weeks before predicted transplant. |
| Respiratory syncytial virus-specific monoclonal antibodya | – | |
| Pneumococcal (PCV) | – | |
| DTPa-HepB-IPV-Hib | An accelerated vaccination schedule can be used for hepatitis B. See Table. Accelerated hepatitis b vaccination schedules for people with imminent risk of exposure. | |
| Meningococcal (MenACWY)a | The number of doses depends on the person’s age and vaccine formulations.See Meningococcal disease. | |
| Meningococcal (MenB)a | The number of doses depends on the person’s age and vaccine formulations.See Meningococcal disease. | |
| 3 months | Rotavirus | Do not give <4 weeks before predicted transplant. Do not start rotavirus vaccination course in infants aged >15 weeks. |
| Pneumococcal (PCV) | – | |
| DTPa-HepB-IPV-Hib | – | |
| 4 months | Meningococcal (MenACWY) | – |
| Meningococcal (MenB) | – | |
| 5 months | Pneumococcal (PCV) | – |
| DTPa-HepB-IPV-Hib | – | |
| 6 months | Influenza | 2 doses if 1st year receiving influenza vaccine, then 1 dose every year. 2 doses will be needed in the 1st year after transplant. |
| MMR | Do not give <4 weeks before predicted transplant. | |
| Hepatitis Aa | Recommended for liver transplant candidates. The combination hepatitis A-hepatitis B vaccine may be appropriate for people who are about to receive a liver transplant if they are not immune to either disease. See Table. Combination hepatitis A-hepatitis B vaccines. | |
| COVID-19 | 2 primary doses and can consider a 3rd dose based on individual risk–benefit assessment. | |
| 9 months | Varicella | Do not give <4 weeks before predicted transplant. |
| Meningococcal (MenACWY) | – | |
| 12 months | Pneumococcal (PCV) | – |
| MMR | Do not give <4 weeks before predicted transplant. | |
| Varicella | Do not give <4 weeks before predicted transplant. | |
| Meningococcal (MenB) | – | |
| 13 months | DTPa-HepB-IPV-Hib | – |
| MMR | Do not give <4 weeks before predicted transplant. | |
| Meningococcal (MenACWY) | – | |
| Hepatitis A | – | |
| 4 years | Pneumococcal (PPV) | 1 dose at age ≥4 years; then 2nd dose 5 ears later. |
| DTPa-HepB-IPV-Hib | – | |
| From 9 years | HPV | 3-dose schedule at 0, 2 and 6 months if immunocompromised |
| 11 years | dTpa | – |
| From 18 years | Recombinant zoster vaccine | 2 doses before transplant |
|
Acronyms used:
Footnotes: |
||
Related chapters
Page history
Last updated
Last reviewed